MorphoSys AG

MorphoSys AG is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. MorphoSys AG is not a good growth stock. MorphoSys AG is not very popular among insiders. MorphoSys AG is a mediocre stock to choose.
Log in to see more information.
MorphoSys AG engages in the development of antibodies for therapeutic, diagnostics, and research app...
MOR Fundamental Data by TradingView

News

Merger Squeeze-Out of MorphoSys Minority Shareholders Approved at 2024 Annual General Meeting
Merger Squeeze-Out of MorphoSys Minority Shareholders Approved at 2024 Annual General Meeting

Accesswire MUNICH, GERMANY / ACCESSWIRE / August 27, 2024 / MorphoSys AG today announced that its shareholders approved all resolutions proposed by the company's Management Board and Supervisory Board at its...\n more…

Equities Analysts Set Expectations for MorphoSys AG's Q2 2024 Earnings (NASDAQ:MOR)
Equities Analysts Set Expectations for MorphoSys AG's Q2 2024 Earnings (NASDAQ:MOR)

Ticker Report MorphoSys AG (NASDAQ:MOR - Free Report) - Equities research analysts at Leerink Partnrs upped their Q2 2024 earnings estimates for shares of MorphoSys in a research note issued to investors on...\n more…

BNP Paribas Financial Markets Boosts Stock Position in MorphoSys AG (NASDAQ:MOR)
BNP Paribas Financial Markets Boosts Stock Position in MorphoSys AG (NASDAQ:MOR)

Zolmax BNP Paribas Financial Markets grew its holdings in MorphoSys AG (NASDAQ:MOR - Free Report) by 130.4% in the first quarter, according to its most recent disclosure with the Securities and Exchange...\n more…

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates Tender Offer Expiring August 2, 2024, of MorphoSys AG MOR
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates Tender Offer Expiring August 2, 2024, of MorphoSys AG MOR

Globe Newswire NEW YORK, July 16, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the M&A Class Action Firm ), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS...\n more…

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates Tender Offer Expiring August 2, 2024, of MorphoSys AG - MOR
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates Tender Offer Expiring August 2, 2024, of MorphoSys AG - MOR

PR Newswire SHAREHOLDER ALERT: The M&A Class Action Firm Investigates Tender Offer Expiring August 2, 2024, of MorphoSys AG - MOR SHAREHOLDER ALERT: The M&A Class Action Firm Investigates Tender Offer Expiring...\n more…

MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market
MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market

Business Wire MorphoSys AG (FSE: MOR; NASDAQ: MOR) today announced that it has formally notified the Nasdaq Stock Market of its intention to voluntarily delist its American Depositary Shares (ADSs) from the Nasdaq...\n more…